Gerd Kochendoerfer's most recent trade in ATAI Life Sciences N.V. was a trade of 50,000 Common Stock done at an average price of $5 . Disclosure was reported to the exchange on June 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ATAI Life Sciences N.V. | Gerd Kochendoerfer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 26 Jun 2026 | 50,000 | 0 | - | 5 | 250,000 | Common Stock |
| ATAI Life Sciences N.V. | Gerd Kochendoerfer | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2026 | 50,000 | 1,400,000 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Gerd Kochendoerfer | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. | 26 Jun 2026 | 50,000 | 50,000 | - | 1.6 | 80,000 | Common Stock |
| ATAI Life Sciences N.V. | Gerd Kochendoerfer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 675,000 | 675,000 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Gerd Kochendoerfer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 150,000 | 150,000 | - | - | Restricted Stock Units | |
| ATAI Life Sciences N.V. | Gerd Kochendoerfer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,450,000 | 1,450,000 | - | - | Stock Option |